Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Journal of Pharmaceutical Sciences
|
January 22, 2015
Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties
Christine Grossjohann, Dolores R Serrano, Krzysztof J Paluch, et al.
European Journal of Medicinal Chemistry
|
August 16, 2011
Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe
Niamh M O'Boyle, Miriam Carr, Lisa M Greene, et al.
Bioorganic & Medicinal Chemistry
|
January 29, 2020
Optimisation of estrogen receptor subtype-selectivity of a 4-Aryl-4H-chromene scaffold previously identified by virtual screening
Miriam Carr, Andrew J S Knox, Daniel K Nevin, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2021
Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4
Azizah M Malebari, Shu Wang, Thomas F Greene, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 14, 2019
3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells
Shu Wang, Azizah M Malebari, Thomas F Greene, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2025
Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. <i>Pharmaceuticals</i> 2021, <i>14</i>, 1119
Azizah M Malebari, Shu Wang, Thomas F Greene, et al.
Journal of Medicinal Chemistry
|
December 19, 2015
Synthesis and Biochemical Evaluation of 3-Phenoxy-1,4-diarylazetidin-2-ones as Tubulin-Targeting Antitumor Agents
Thomas F Greene, Shu Wang, Lisa M Greene, et al.
Science Advances
|
July 19, 2023
More than bad luck: Cancer and aging are linked to replication-driven changes to the epigenome
Christopher J Minteer, Kyra Thrush, John Gonzalez, et al.
Acta Neuropathologica Communications
|
March 2, 2021
COllaborative Neuropathology NEtwork Characterizing ouTcomes of TBI (CONNECT-TBI)
Douglas H Smith, Jean-Pierre Dollé, Kamar E Ameen-Ali, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Journal of Pharmaceutical Sciences
|
January 22, 2015
Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties
Christine Grossjohann, Dolores R Serrano, Krzysztof J Paluch, et al.
European Journal of Medicinal Chemistry
|
August 16, 2011
Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe
Niamh M O'Boyle, Miriam Carr, Lisa M Greene, et al.
Bioorganic & Medicinal Chemistry
|
January 29, 2020
Optimisation of estrogen receptor subtype-selectivity of a 4-Aryl-4H-chromene scaffold previously identified by virtual screening
Miriam Carr, Andrew J S Knox, Daniel K Nevin, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2021
Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4
Azizah M Malebari, Shu Wang, Thomas F Greene, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 14, 2019
3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells
Shu Wang, Azizah M Malebari, Thomas F Greene, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2025
Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. <i>Pharmaceuticals</i> 2021, <i>14</i>, 1119
Azizah M Malebari, Shu Wang, Thomas F Greene, et al.
Journal of Medicinal Chemistry
|
December 19, 2015
Synthesis and Biochemical Evaluation of 3-Phenoxy-1,4-diarylazetidin-2-ones as Tubulin-Targeting Antitumor Agents
Thomas F Greene, Shu Wang, Lisa M Greene, et al.
Science Advances
|
July 19, 2023
More than bad luck: Cancer and aging are linked to replication-driven changes to the epigenome
Christopher J Minteer, Kyra Thrush, John Gonzalez, et al.
Acta Neuropathologica Communications
|
March 2, 2021
COllaborative Neuropathology NEtwork Characterizing ouTcomes of TBI (CONNECT-TBI)
Douglas H Smith, Jean-Pierre Dollé, Kamar E Ameen-Ali, et al.
Page
of 5